These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 10990198

  • 21. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M, Carreira F, Theisen P, Laires A, Fisher CW, Rueff J, Estabrook RW, Vermeulen NP.
    Mutat Res; 1999 Apr 26; 441(1):73-83. PubMed ID: 10224324
    [Abstract] [Full Text] [Related]

  • 22. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, Breimer DD.
    AIDS; 2001 Mar 09; 15(4):483-91. PubMed ID: 11242145
    [Abstract] [Full Text] [Related]

  • 23. Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression.
    Crespi CL, Fox L, Stocker P, Hu M, Steimel DT.
    Eur J Pharm Sci; 2000 Nov 09; 12(1):63-8. PubMed ID: 11121734
    [Abstract] [Full Text] [Related]

  • 24. Utility of P-glycoprotein and organic cation transporter 1 double-transfected LLC-PK1 cells for studying the interaction of YM155 monobromide, novel small-molecule survivin suppressant, with P-glycoprotein.
    Iwai M, Minematsu T, Li Q, Iwatsubo T, Usui T.
    Drug Metab Dispos; 2011 Dec 09; 39(12):2314-20. PubMed ID: 21918035
    [Abstract] [Full Text] [Related]

  • 25. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
    Inui H, Maeda A, Ohkawa H.
    Biochemistry; 2007 Sep 04; 46(35):10213-21. PubMed ID: 17691855
    [Abstract] [Full Text] [Related]

  • 26. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
    van der Sandt IC, Blom-Roosemalen MC, de Boer AG, Breimer DD.
    Eur J Pharm Sci; 2000 Sep 04; 11(3):207-14. PubMed ID: 11042226
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase.
    Hu M, Li Y, Davitt CM, Huang SM, Thummel K, Penman BW, Crespi CL.
    Pharm Res; 1999 Sep 04; 16(9):1352-9. PubMed ID: 10496649
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
    Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF.
    J Pharmacol Exp Ther; 2000 May 04; 293(2):376-82. PubMed ID: 10773005
    [Abstract] [Full Text] [Related]

  • 33. Transfected MDCK cell line with enhanced expression of CYP3A4 and P-glycoprotein as a model to study their role in drug transport and metabolism.
    Kwatra D, Budda B, Vadlapudi AD, Vadlapatla RK, Pal D, Mitra AK.
    Mol Pharm; 2012 Jul 02; 9(7):1877-86. PubMed ID: 22676443
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Kinetics of testosterone 6beta-hydroxylation in the reconstituted system with similar ratios of purified CYP3A4, NADPH-cytochrome p450 oxidoreductase and cytochrome B5 to human liver microsomes.
    Taguchi M, Imaoka S, Yoshii K, Kobayashi K, Hosokawa M, Shimada N, Funae Y, Chiba K.
    Res Commun Mol Pathol Pharmacol; 2001 Jul 02; 109(1-2):53-63. PubMed ID: 11458985
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
    Cummins CL, Mangravite LM, Benet LZ.
    Pharm Res; 2001 Aug 02; 18(8):1102-9. PubMed ID: 11587480
    [Abstract] [Full Text] [Related]

  • 40. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
    Cummins CL, Jacobsen W, Benet LZ.
    J Pharmacol Exp Ther; 2002 Mar 02; 300(3):1036-45. PubMed ID: 11861813
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.